 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/15/2020 |
$88.18 |
$89.88 |
$88.18 |
$89.26 |
8.49M | | 01/16/2020 |
$89.31 |
$89.80 |
$88.92 |
$89.26 |
7.07M | | 01/17/2020 |
$89.13 |
$89.27 |
$87.79 |
$88.00 |
10.12M | | 01/21/2020 |
$87.68 |
$88.53 |
$87.57 |
$87.99 |
13.55M | | 01/22/2020 |
$88.03 |
$88.17 |
$87.15 |
$87.21 |
6.44M |
|
|
| AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health. |
|
|
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on January 15, 2020, ABBV opened at $88.18, traded as high as $89.88 and as low as $88.18, and closed at $89.26. Trading volume was a total of 8.49M shares. On January 16, 2020, ABBV opened at $89.31, traded as high as $89.80 and as low as $88.92, and closed at $89.26. Trading volume was a total of 7.07M shares. On January 17, 2020, ABBV opened at $89.13, traded as high as $89.27 and as low as $87.79, and closed at $88.00. Trading volume was a total of 10.12M shares. On January 21, 2020, ABBV opened at $87.68, traded as high as $88.53 and as low as $87.57, and closed at $87.99. Trading volume was a total of 13.55M shares. On January 22, 2020, ABBV opened at $88.03, traded as high as $88.17 and as low as $87.15, and closed at $87.21. Trading volume was a total of 6.44M shares.
ABBV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
01/22/2020 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$87.21 |
|
| Starting shares: |
284.74 |
|
| Ending shares: |
378.70 |
|
| Dividends reinvested/share: |
$19.17 |
|
| Total return: |
230.26% |
|
| Average Annual Total Return: |
18.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$33,035.15 |
|
| Years: |
7.06 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/02/2013 |
|
| End date: |
01/22/2020 |
|
| Start price/share: |
$35.12 |
|
| End price/share: |
$87.21 |
|
| Dividends collected/share: |
$19.17 |
|
| Total return: |
202.90% |
|
| Average Annual Total Return: |
17.00% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$30,284.75 |
|
| Years: |
7.06 |
|
|
|
| Date |
Close |
| 01/15/2020 | $89.26 | | 01/16/2020 | $89.26 | | 01/17/2020 | $88.00 | | 01/21/2020 | $87.99 | | 01/22/2020 | $87.21 |
|
|
